Thu Oct 7, 2021 – 1:19 pm EDTThu Oct 7, 2021 – 1:54 pm EDT
(LifeSiteNews) — Pfizer on Thursday officially requested an emergency use authorization (EUA) to dole out its experimental COVID vaccine to young children between the ages of 5 and 11.
In an October 7 tweet announcing the move, Pfizer argued that its request seeking an EUA from the Food and Drug Administration (FDA) is “an important step in our ongoing effort against #COVID19.”
“We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat,” the pharmaceutical company added.
The news comes in spite of the fact that children are at extremely low risk of suffering severe complications or death from contracting COVID-19, and regardless of studies showing the jabs themselves present significant health risks to young people.
UPDATE: We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12. pic.twitter.com/72Z2HXlkOx
— Pfizer Inc. (@pfizer) October 7, 2021
School districts and governments have begun to mandate the jabs for “eligible” students attending classes during the 2021-2022 school year.
On Friday,
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
